Bear Stearns Takes 5.2% Stake in Biopsys Medical
- Share via
(Dow Jones)
IRVINE — Bear Stearns Cos. has taken a 5.2% stake in Biopsys Medical Inc., Irvine-based developer of devices to diagnose breast cancer, according to documents filed with the Securities and Exchange Commission.
Bear Stearns said it bought the stock in “the ordinary course of business as a broker/dealer” and has no extraordinary plans for Biopsys. Bear Stearns owns 510,615 shares of Biopsys stock.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
